Fresenius Medical Care (FMC) finds itself amongst the leading patient-oriented renal therapy company throughout the entire world. Administering 32 million dialysis treatments throughout more than 215,000 patients across North America, Europe, Asia-Pacific, Africa, and Latin America, the company has surely made its mark around the globe. Unfortunately, however, this widespread reach has sent millions of patients to fear for their health, as two of FMCs most prevalent dialysis drugs (GranuFlo and NaturaLyte) have been connected to numerous cases of increased disk for cardiopulmonary arrest and sudden cardiac death.
Fresenius Medical Care has a reach throughout the United States similar to that of the world. With 1,800 kidney dialysis clinics treating close to 138,000 patients, FMC is the largest provider of dialysis services and products in the country. The company has 45,000 employees and a serious responsibility to provide health services for many, many individuals across the nation.
Recent reports from the U.S. Food and Drug Administration (FDA) have linked a number of serious heart risks to the exposure to both GranuFlo and NaturaLyte dialysis treatments. Greg Coleman Law is currently taking on cases for any Tennessee residents who may be at risk. If you or a loved one has suffered any adverse side effects are receiving either GranuFlo or NaturaLyte dialysis treatment, you may be entitled to compensation.
To learn more about your legal options, please fill out a Free Case Review on this page.
Fresenium Medical Care Quick Facts
Across the world, about 2 million people suffer from some form of chronic kidney failure. When kidney failure occurs, the treatment used to correct the medical issue is a process referred to as dialysis. Fresenium, as the largest provider, has quite a large number of dialysis products. Some of most popular dialysis products include:
Related disposable products
The company is headquartered in Massachusetts in the United States. In 2010, the company took in $12.5 billion in revenue, highlighting the widespread success and reach of this organization. As a dominant player in the dialysis market, the majority of physicians and health care professionals recommended these FMC treatments as the best means to treat kidney problems.
If you or a loved one has suffered from any heart problems following GranuFlo or NaturaLyte treatment, contact our personal injury law firm today for a free, no-obligation consultation.
FMC Had Knowledge of Dialysis Heart Risks
On March 29, 2012, the FDA issued a Class 1 recall of both GranuFlo and NaturaLyte. Class 1 recalls indicate the most serious of all recalls, as this means that the recalled product contains serious adverse health consequences or death. While the FDA made this announcement in March of 2012, leaked information suggests that the company had been aware of the health risks in GranuFlo and NaturaLyte for almost 2 years.
A case-control study was conducted by Fresenius Medical Care between January 1 and December 31 of 2010 with the purpose of determining risk factors linked from dialysis patients to cardiopulmonary arrest. At the study's conclusion, 841 patients who were treated in 667 FMC facilities suffered from cardiopulmonary arrests that ended in a fatality. The results of the data point to the dangers of these dialysis drugs. Patients studied shed light on the fact that FMC treatments made them 6 times more likely to develop cardiopulmonary arrests if they had a high level of bicarbonate prior to treatment.
After the results of the study were conclusive, all FMC physicians and facilities were sent a memo outlining what action should be taken for dialysis patients with high bicarbonate levels prior to administering any dialysis treatment. However, Fresenius Medical Care neglected to make this announcement externally. Only those internal FMC health care professionals were informed, leaving the public at large in the dark. The information only became available to the public once the memo was leaked to the FDA.
If you or a loved one has developed any heart issues following the use of GranuFlo or NaturaLyte, please contact our Knoxville personal injury firm immediately.
GranuFlo and NaturaLyte Lawsuits
Approximately 400,000 patients receive dialysis drugs each year in the United States. Estimates have projected that about one-third of these patients have been given either GranuFlo or NaturaLyte. Due to the serious side effects linked to these drugs, a massive number of lawsuits are being constructed. Greg Coleman Law believes that Fresenius Medical Care must pay for the damages that they have caused so many individuals throughout the nation and in Tennessee specifically.
Our dangerous drugs attorneys are committed to protecting the rights of Knoxville residents through the pursuit of justice. Through thorough research and investigation, we build a case that puts our clients in the best position to win. Our goal is to win the maximum compensation possible for you.
Fill out a Free Case Review above to get started.